Results 91 to 100 of about 513,363 (187)

Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer

The Prostate, 2018
Pedro Isaacsson Velho, J. Silberstein, M. Markowski, Jun Luo, T. Lotan, W. Isaacs, E. Antonarakis   +6 more
semanticscholar   +1 more source

Zašto je rak prostate najvarijabilniji zloćudni tumor?

Medix (Zagreb), 2005
Rak prostate jedan je od najviše istraživanih zloćudnih tumora. Rezultat tih kliničkih i temeljno-znanstvenih istraživanja je napredak u dijagnostici i liječenju. Taj napredak bi zasigurno mogao i morao biti veći. Još uvijek je mnogo razloga zbog kojih je rak prostate u vrhu interesa svjetske onkologije.
openaire   +3 more sources

Metastatski, na kastracijo odporen rak prostate – kemoterapija, novejša hormonska zdravila in podporno zdravljenje

, 2023
najugodnejšo prognozo imajo bolniki z zasevki le v bezgavkah, najslabšo pa bolniki z zasevki v visceralnih organih. Dva citostatika – docetaksel in kabazitaksel – ter dve novejši hormonski zdravili – enzalutamid in abirateron acetat – podaljšujeta preživetje teh bolnikov.
openaire   +1 more source

Human prostate‐infiltrating CD8+ T lymphocytes are oligoclonal and PD‐1+

The Prostate, 2009
K. Sfanos, T. Bruno, A. Meeker, A. D. De Marzo, W. Isaacs, C. Drake   +5 more
semanticscholar   +1 more source

Praćenje onkoloških bolesnika – kliničke preporuke Hrvatskog društva za internističku onkologiju HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa [Cancer patients follow-up – Croatian society of medical oncology clinical guidelines Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer]

, 2016
The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely
Gnjidić, Milena, Vojnović, Željko, Čonkaš, Mislav, Grubišić Čabo, Filip, Belev, Borislav, Budisavljević, Anuška, Gilja, Ivan, Dedić Plavetić, Natalija, Šeparović, Robert, Vrbanec, Damir   +9 more
openaire   +1 more source

A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination

The Prostate, 2015
C. Paller, M. Rudek, Xiaoping Zhou, W. Wagner, T. Hudson, Nicole M. Anders, H. Hammers, D. Dowling, Serina King, E. Antonarakis, C. Drake, M. Eisenberger, S. Denmeade, G. Rosner, M. Carducci   +14 more
semanticscholar   +1 more source

Investigation of the relationship between endothelial nitric oxide synthase T786C polymorphism and PSA, PSA derivatives, and prostate cancer in the Turkish population. [PDF]

J Med Biochem, 2023
Balci S, Akbayir S, Bozlu M, Tamer L.
europepmc   +1 more source

Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner

The Prostate, 2008
T. Harris, Edward L. Hipkiss, S. Borzillary, S. Wada, J. Grosso, Hung-Rong Yen, D. Getnet, T. Bruno, Monica V. Goldberg, D. Pardoll, T. DeWeese, C. Drake   +11 more
semanticscholar   +1 more source

Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer.

Carcinogenesis, 2014
D. Ryszawy, M. Sarna, M. Rak, K. Szpak, S. Kędracka-Krok, M. Michalik, M. Siedlar, E. Zuba-Surma, K. Burda, W. Korohoda, Z. Madeja, J. Czyż   +11 more
semanticscholar   +1 more source